News
I
May 01, 2023
Promising New Data of SIM01 Showed in IMPACT Study
GenieBiome is proud to offer a novel microbiome formula, SIM01, to bridge the unmet needs of COVID-19 and other emerging infections.
In a large-scale, double-blind, randomized trial (IMPACT Study) led by the Microbiota I-Center (MagIC) (香港微生物菌群創新中心) of The Chinese University of Hong Kong 香港中文大學, SIM01 significantly reduced the risk of COVID-19 and other infections through the restoration of gut dysbiosis.
GenieBiome Limited 精進微生物科技有限公司
Microbiota I-Center (MagIC) (香港微生物菌群創新中心)
CUHK Medicine
#SIM01
